Double Jeopardy: Precapillary Pulmonary Hypertension Increases the Risk of Hospitalization and Death from COVID-19
- PMID: 35584345
- PMCID: PMC9716902
- DOI: 10.1164/rccm.202205-0884ED
Double Jeopardy: Precapillary Pulmonary Hypertension Increases the Risk of Hospitalization and Death from COVID-19
Figures
Comment on
-
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.Am J Respir Crit Care Med. 2022 Sep 1;206(5):573-583. doi: 10.1164/rccm.202112-2761OC. Am J Respir Crit Care Med. 2022. PMID: 35549842 Free PMC article.
References
-
- Yek C, Warner S, Wiltz JL, Sun J, Adjei S, Mancera A, et al. Risk factors for severe COVID-19 outcomes among persons aged ⩾18 years who completed a primary COVID-19 vaccination series—465 health care facilities, United States, December 2020–October 2021. MMWR Morb Mortal Wkly Rep . 2022;71:19–25. - PMC - PubMed
-
- Greene R, Lind S, Jantsch H, Wilson R, Lynch K, Jones R, et al. Pulmonary vascular obstruction in severe ARDS: angiographic alterations after i.v. fibrinolytic therapy. AJR Am J Roentgenol . 1987;148:501–508. - PubMed
-
- Zapol WM, Snider MT. Pulmonary hypertension in severe acute respiratory failure. N Engl J Med . 1977;296:476–480. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
